Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry - Potential for diagnostic applications

被引:53
作者
Fetsch, PA
Simone, NL
Bryant-Greenwood, PK
Marincola, FM
Filie, AC
Petricoin, EF
Liotta, LA
Abati, A
机构
[1] NCI, Cytophathol Sect, NIH, Pathol Lab, Bethesda, MD 20892 USA
[2] NCI, Surg Branch, NIH, Bethesda, MD 20892 USA
[3] US FDA, Clin Prote Program, Bethesda, MD 20014 USA
关键词
proteomics; SELDI; protein fingerprint; protein biochip; archival cytologic samples; melanoma; clear cell sarcoma; renal cell carcinoma; reactive mesothelial cells;
D O I
10.1092/HCRY7A2X09D9GYYA
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Proteomic studies of cells via surface-enhanced laser desorption/ionization spectrometry (SELDI) analysis have enabled rapid, reproducible protein profiling directly from crude samples. We applied this technique to archival cytology material to determine whether distinct, reproducible protein fingerprints could be identified for potential diagnostic purposes in blinded specimens. Rapid Romanowsky-stained cytocentrifuged specimens from fine-needle aspirates of metastatic malignant melanoma (with both known cutaneous primary and unknown primary sites), clear cell sarcoma, and renal cell card. noma and reactive effusions were examined using the SELDI technology. A unique characteristic fingerprint was identified for each disease entity. Fifteen "blinded" unknown samples then were analyzed. When the protein profile fingerprints were plotted against the known fingerprints for the aforementioned diagnoses, the appropriate match or diagnosis was obtained in 13 (87%) of 15 cases. These preliminary findings suggest a substantial potential for SELDI applications to specific pathologic diagnoses.
引用
收藏
页码:870 / 876
页数:7
相关论文
共 40 条
  • [1] Proteomic analysis of human prostate cancer
    Ahram, M
    Best, CJM
    Flaig, MJ
    Gillespie, JW
    Leiva, IM
    Chuaqui, RF
    Zhou, G
    Shu, HJ
    Duray, PH
    Linehan, WM
    Raffeld, M
    Ornstein, DK
    Zhao, YM
    Petricoin, EF
    Emmert-Buck, MR
    [J]. MOLECULAR CARCINOGENESIS, 2002, 33 (01) : 9 - 15
  • [2] Best CJM, 2000, ANAL CELL PATHOL, V20, P1
  • [3] Celis JE, 2000, ELECTROPHORESIS, V21, P2115
  • [4] Chang AE, 1998, CANCER, V83, P1664, DOI 10.1002/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO
  • [5] 2-G
  • [6] Detection of β-defensins secreted by human oral epithelial cells
    Diamond, DL
    Kimball, JR
    Krisanaprakornkit, S
    Ganz, T
    Dale, BA
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 256 (1-2) : 65 - 76
  • [7] Molecular profiling of clinical tissue specimens -: Feasibility and applications
    Emmert-Buck, MR
    Strausberg, RL
    Krizman, DB
    Bonaldo, MF
    Bonner, RF
    Bostwick, DG
    Brown, MR
    Buetow, KH
    Chuaqui, RF
    Cole, DA
    Duray, PH
    Englert, CR
    Gillespie, JW
    Greenhut, S
    Grouse, L
    Hillier, LW
    Katz, KS
    Klausner, RD
    Kuznetzov, V
    Lash, AE
    Lennon, G
    Linehan, WM
    Liotta, LA
    Marra, MA
    Munson, PJ
    Ornstein, DK
    Prabhu, VV
    Prange, C
    Schuler, GD
    Soares, MB
    Tolstoshev, CM
    Vocke, CD
    Waterston, RH
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) : 1109 - 1115
  • [8] A rapid method to capture and screen for transcription factors by SELDI mass spectrometry
    Forde, CE
    Gonzales, AD
    Smessaert, JM
    Murphy, GA
    Shields, SJ
    Fitch, JP
    McCutchen-Maloney, SL
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 290 (04) : 1328 - 1335
  • [9] Gillespie JW, 2001, CANCER J, V7, P32
  • [10] Hanash SM, 2002, PROTEOMICS, V2, P69, DOI 10.1002/1615-9861(200201)2:1<69::AID-PROT69>3.3.CO